Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.

Khadilkar V, Radjuk KA, Bolshova E, Khadgawat R, El Kholy M, Desai M, Peterkova V, Mericq V, Kratzsch J, Siepl EC, Martin D, Lopez P, Ji HJ, Bae YJ, Lee JH, Saenger PH.

J Clin Endocrinol Metab. 2014 Jan;99(1):126-32. doi: 10.1210/jc.2013-2502. Epub 2013 Dec 20.

PMID:
24170106
2.

Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).

Péter F, Bidlingmaier M, Savoy C, Ji HJ, Saenger PH.

J Clin Endocrinol Metab. 2012 Feb;97(2):400-7. doi: 10.1210/jc.2011-2234. Epub 2011 Dec 7.

PMID:
22162481
3.

Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.

Hwang JS, Lee HS, Chung WY, Han HS, Jin DK, Kim HS, Ko CW, Lee BC, Lee DY, Lee KH, Shin JH, Suh BK, Yoo HW, Ji HJ, Lee JH, Bae YJ, Kim DH, Yang SW.

Eur J Endocrinol. 2013 Jul 6;169(2):179-85. doi: 10.1530/EJE-13-0148. Print 2013 Aug.

4.

Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.

Biller BM, Ji HJ, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ.

J Clin Endocrinol Metab. 2011 Jun;96(6):1718-26. doi: 10.1210/jc.2010-2819. Epub 2011 Mar 16.

PMID:
21411551
5.

Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency.

Peter F, Savoy C, Ji HJ, Juhasz M, Bidlingmaier M, Saenger P.

Eur J Endocrinol. 2009 Mar;160(3):349-55. doi: 10.1530/EJE-08-0703. Epub 2008 Dec 12.

6.

12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.

Biller BM, Ji HJ, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ.

Pituitary. 2013 Sep;16(3):311-8. doi: 10.1007/s11102-012-0422-8.

PMID:
22915288
7.

Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.

Bidlingmaier M, Kim J, Savoy C, Kim MJ, Ebrecht N, de la Motte S, Strasburger CJ.

J Clin Endocrinol Metab. 2006 Aug;91(8):2926-30. Epub 2006 May 23.

PMID:
16720652
8.

Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.

Azcona C, Preece MA, Rose SJ, Fraser N, Rappaport R, Ranke MB, Savage MO.

Clin Endocrinol (Oxf). 1999 Dec;51(6):787-92.

PMID:
10619985
9.

Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.

Albertsson Wikland K, Alm F, Aronsson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson S, Kriström B, Marcus C, Moëll C, Nilsson KO, Ritzén M, Tuvemo T, Westgren U, Westphal O, Aman J.

Acta Paediatr Suppl. 1999 Feb;88(428):80-4.

PMID:
10102059
11.

A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.

Peterkova V, Arslanoglu I, Bolshova-Zubkovskaya E, Romer T, Zdravkovic D, Kratzsch J, Ji HJ, Savoy C, Saenger P.

Horm Res. 2007;68(6):288-93. Epub 2007 Jul 11.

PMID:
17627092
12.

A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency.

Reiter EO, Attie KM, Moshang T Jr, Silverman BL, Kemp SF, Neuwirth RB, Ford KM, Saenger P; Genentech, Inc.-Alkermes, Inc. Collaborative Study Group.

J Clin Endocrinol Metab. 2001 Oct;86(10):4700-6.

PMID:
11600528
14.

Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.

Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG.

J Clin Endocrinol Metab. 2008 Feb;93(2):352-7. Epub 2007 Nov 13.

PMID:
18000092
15.

Prediction of response to growth hormone treatment in pre-pubertal children with growth hormone deficiency.

Valle D, Bartolotta E, Caruso M, De Sanctis C, Falorni A, Saggese G, Pasquino AM, Tauchmanova L, Cicognani A.

J Endocrinol Invest. 2011 Jun;34(6):e126-30. doi: 10.3275/7322. Epub 2010 Oct 27.

PMID:
21042043
16.

Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.

Zucchini S, Pirazzoli P, Baronio F, Gennari M, Bal MO, Balsamo A, Gualandi S, Cicognani A.

J Clin Endocrinol Metab. 2006 Nov;91(11):4271-6. Epub 2006 Aug 15.

PMID:
16912138
17.

Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency.

Roemmler J, Gockel A, Otto B, Bidlingmaier M, Schopohl J.

Clin Endocrinol (Oxf). 2012 Jan;76(1):88-95. doi: 10.1111/j.1365-2265.2011.04146.x.

PMID:
21682757
18.

Efficacy and safety of a new ready-to-use recombinant human growth hormone solution.

Romer T, Peter F, Saenger P, Starzyk J, Koehler B, Korman E, Walczak M, Wasik R, Ginalska-Malinowska M, Solyom E, Berghout A.

J Endocrinol Invest. 2007 Jul-Aug;30(7):578-89.

PMID:
17848841
19.

Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.

Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler S, Frane J, Lippe B.

J Clin Endocrinol Metab. 2005 Sep;90(9):5247-53. Epub 2005 Jul 5.

PMID:
15998780
20.

Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study.

Jung H, Land C, Nicolay C, De Schepper J, Blum WF, Schönau E.

Eur J Endocrinol. 2009 Feb;160(2):149-56. doi: 10.1530/EJE-08-0301. Epub 2008 Nov 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk